Literature DB >> 12670626

mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish.

Owen A Ross1, Rose McCormack, Lynn D Maxwell, R Alistair Duguid, Derek J Quinn, Yvonne A Barnett, I Maeve Rea, Omar M A El-Agnaf, J Mark Gibson, Andrew Wallace, Derek Middleton, Martin D Curran.   

Abstract

Polymorphism of the mtDNA genome has been implicated as playing a role in the development and pathogenesis of Parkinson's disease (PD). A PCR-RFLP methodology was employed to generate genetic haplotypes for a cohort of 90 PD sufferers. No association was observed between the various mtDNA haplotypes observed and PD in comparison to healthy aged controls. The longevity-associated European J haplogroup and T haplogroup were identified and were both found to be in tight linkage with the mt4216C polymorphism. The mt4216C variant was observed at a significantly increased frequency in the PD cases (28%) in comparison to the healthy aged controls (15%; p=0.014). However, when the frequency of the mt4216C variant was examined in a cohort of 200 young controls (18-45 years) a similar frequency to the PD cases (25%) was observed. The frequencies obtained for the two branches of the J haplogroup (J1 and J2) and the T haplogroup in the cohort of PD subjects also reflected those observed for the young controls used in the previous longevity study. These findings lead one to postulate that the mt4216C variant, in linkage with the mtDNA TJ cluster, may influence mitochondrial dysfunction, resulting in an increased risk of PD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670626     DOI: 10.1016/s0531-5565(02)00266-8

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  30 in total

Review 1.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

2.  Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease.

Authors:  Russell H Swerdlow; Bradley Weaver; Amy Grawey; Connie Wenger; Eric Freed; Bradford B Worrall
Journal:  J Neurol Sci       Date:  2006-06-19       Impact factor: 3.181

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

4.  Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Authors:  David K Simon; Nathan Pankratz; Diane K Kissell; Michael W Pauciulo; Cheryl A Halter; Alice Rudolph; Ronald F Pfeiffer; William C Nichols; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

5.  Specific polymorphic variation in the mitochondrial genome and increased in-hospital mortality after severe trauma.

Authors:  Jeffrey A Canter; Patrick R Norris; Jason H Moore; Judith M Jenkins; John A Morris
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

6.  Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort.

Authors:  Katarzyna Gaweda-Walerych; Aleksandra Maruszak; Krzysztof Safranow; Monika Bialecka; Gabriela Klodowska-Duda; Krzysztof Czyzewski; Jaroslaw Slawek; Monika Rudzinska; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Jeffrey A Canter; Maria Barcikowska; Cezary Zekanowski
Journal:  J Neural Transm (Vienna)       Date:  2008-09-23       Impact factor: 3.575

7.  Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background.

Authors:  Helen Latsoudis; Cleanthe Spanaki; Grigoris Chlouverakis; Andreas Plaitakis
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

8.  Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Authors:  Emily R Holzinger; Todd Hulgan; Ronald J Ellis; David C Samuels; Marylyn D Ritchie; David W Haas; Asha R Kallianpur; Cinnamon S Bloss; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David M Simpson; Donald R Franklin; Debralee Rosario; Doug Selph; Scott Letendre; Igor Grant
Journal:  J Neurovirol       Date:  2012-10-17       Impact factor: 2.643

9.  Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia.

Authors:  Jaana Autere; Jukka S Moilanen; Saara Finnilä; Hilkka Soininen; Arto Mannermaa; Päivi Hartikainen; Merja Hallikainen; Kari Majamaa
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

10.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.